However, unlike genetic deletion, ASO treatment significantly decreased the tumor volume (by ~50%), suggesting that these ASOs have extra effects other than knocking down Malat1. Unfortunately, the molecular mechanisms underlying the Malat1 gene deletion and ASO effects remain unknown. This evidence concerns the gene MALAT1 and neoplasm.